top of page
Cyclophosphamide 1000

Cyclophosphamide 1000

SKU: VHGAC02

Cyclophosphamide 1000 mg Injection

Cyclophosphamide 1000 mg Injection is a potent alkylating anticancer and immunosuppressive agent used in the treatment of a wide range of malignancies. It acts by inhibiting DNA replication in rapidly dividing cancer cells, leading to effective tumor control. The product is widely used in oncology and immunotherapy protocols worldwide.

Product Details

  • Generic Name: Cyclophosphamide

  • Strength: 1000 mg (1 g)

  • Dosage Form: Sterile lyophilized powder for injection

  • Route of Administration: Intravenous (IV) / Intramuscular (IM)

  • Therapeutic Class: Alkylating Agent

Indications

Cyclophosphamide 1000 mg Injection is indicated for the treatment of:

  • Breast cancer

  • Hodgkin’s and Non-Hodgkin’s lymphoma

  • Leukemia

  • Multiple myeloma

  • Ovarian cancer

  • Neuroblastoma and retinoblastoma

  • Selected autoimmune disorders (as prescribed)

Mechanism of Action

Cyclophosphamide interferes with DNA synthesis by forming cross-links in DNA strands, preventing cancer cell division and resulting in cell death.

Key Benefits

  • Broad-spectrum anticancer activity

  • Effective in solid tumors and hematological malignancies

  • Suitable for combination chemotherapy regimens

  • Widely accepted in global oncology protocols

Dosage & Administration

Dosage is individualized based on body surface area (BSA), disease condition, and patient response. The injection should be administered only under the supervision of a qualified healthcare professional.

Storage Conditions

  • Store below 25°C

  • Protect from light and moisture

  • Do not freeze

Precautions

  • For hospital and clinical use only

  • Regular monitoring of blood counts is recommended

  • Ensure adequate hydration during therapy

Regulatory Status

Prescription Drug (Rx only)

Corporate office

Office no 05, Shakar Hieghts, Near Divine Mercy Church, Ramdev Park, Mira road East, Thane 401107

Tel: +917506579315

Follow us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

VHG Pharma © 2022 - All rights reserved

bottom of page